The biological heterogeneity of myeloma can be largely explained by genetic subtypes characterized by primary translocations, or trisomies of chromosomes 3, 5, 7, 9, 11, 15, 19, and 21. In newly diagnosed patients, it is well established that these genetic subtypes have different survival rates.[1][
No takes yet. Share an insight, caveat, or question.
Chng et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: